Opinion - Page 63

Hims & Hers said Saturday it will stop selling what it claims to be a cheaper, compounded version of Novo Nordisk’s obesity pill on its telehealth platform, after health officials called for

China criticized the United States on Friday for withdrawing from the World Health Organization, saying countries should not place domestic politics ahead of international law. The country’s representative, attending a meeting of

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Maybe it’s just that I haven’t eaten lunch yet as I write this Thursday

Roivant and its spinout Priovant said Friday that their immune-modifying drug brepocitinib significantly outperformed placebo in clearing lesions caused by a rare skin disease in a small trial. In the 31–person study,

So you’re a bear in the forest, and you’re hungry. When you trundle toward a raspberry bush and get your first taste of ripe, sweet fruit, dopamine floods your brain, pleasure as

Far fewer people who could benefit from statins actually take the cholesterol-lowering drugs now. Many who start taking them stop. The long list of side effects, detailed in fine print on package

At least nine hospitals or health systems have stopped providing gender-affirming hormones and puberty blockers to young trans people since the start of the year, in the wake of federal rules proposed

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning. It’s a sad week in journalism after The Washington Post laid off

Vertex executives warned that Casgevy, its curative treatment for sickle cell disease, would be slow to reach patients. But few expected it to be this slow. More than two years after its

WASHINGTON — The pharmacy benefit manager reforms that President Trump signed into law on Tuesday could lead to employers buying drugs directly from drugmakers, just like the administration is encouraging individual consumers